In patients with gastroenteropancreatic neuroendocrine tumors, first-line administration of radioligand therapy reduces the risk of disease progression …
Tag:
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More